OSSAMYCIN, A NEW CYTOTOXIC AGENT.
D000230:Adenocarcinoma; D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001419:Bacteria; D003603:Cytotoxins; D056890:Eukaryota; D005658:Fungi; D006367:HeLa Cells; D006801:Humans; D007939:Leukemia L1210; D007942:Leukemia, Experimental; D007951:Leukemia, Myeloid; D018942:Macrolides; D051379:Mice; D009374:Neoplasms, Experimental; D010600:Pharmacology; D012106:Research; D012510:Sarcoma 180; D013302:Streptomyces; D015003:Yeasts
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003603:Cytotoxins; D018942:Macrolides; C008717:ossamycin
ADENOCARCINOMA; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BACTERIA; EXPERIMENTAL LAB STUDY; FUNGI; HELA CELLS; LEUKEMIA L1210; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOCYTIC; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PROTOZOA; SARCOMA 180, CROCKER; STREPTOMYCES; YEASTS